Journal article
Emerging drugs for treating skeletal muscle injury and promoting muscle repair
SM Gehrig, GS Lynch
Expert Opinion on Emerging Drugs | TAYLOR & FRANCIS LTD | Published : 2011
Abstract
Introduction: Musculoskeletal injuries represent a major global public health problem and muscle injury contributes significantly to the burden of disability and suffering. Drugs that can attenuate muscle trauma and/or hasten muscle repair to restore function can help reduce the economic burden and alleviate personal suffering and financial hardship. Areas covered: This review provides an update on some emerging drugs with therapeutic potential for muscle injury including those that could attenuate damage or improve regeneration. Although there are few (if any) drugs in development specifically for muscle injury, there are numerous drugs in development for cardiovascular complications, such ..
View full abstractRelated Projects (3)
Grants
Awarded by Merck
Funding Acknowledgements
[ "The Basic and Clinical Myology Laboratory gratefully acknowledges the generous research grant funding received from the National Health and Medical Research Council of Australia (NHMRC 509313, 566818, 566820), Muscular Dystrophy Association (USA), Association Francaise Contre les Myopathies (France), Pfizer (USA), F. Hoffmann-La Roche (Switzerland) and Merck & Co. (USA).", "SM Gehrig was supported by a National Heart Foundation (NHF) Postgraduate Scholarship (Australia)." ]